Research led by Shanghai Jiao Tong University School of Medicine and the Chan School of Public Health in Boston suggests that there may be more long-term health risks associated with gestational diabetes than previously thought even in women who do not go on to develop type 2 diabetes. Using data…

The Broad Institute of MIT and Harvard today announced a research alliance with Novo Nordisk in diabetes and cardiometabolic diseases. The collaboration aims to advance three programs over the next three years. Two programs will seek drug targets for specific subtypes of type 2 diabetes and the third aims to…

Researchers led by Hiroshi Ohno, MD, PhD, at Japan’s RIKEN Center for Integrative Medical Sciences have identified gut bacteria that reduces insulin resistance and may protect against type 2 diabetes and obesity. Their study, published today in Nature, involved analyzing human fecal microbiomes then corroborating their results with tests on…

Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have discovered that a metabolite found in urine predicts kidney failure from type 2 diabetes five to 10 years early. This new research, published in the Journal of Clinical Investigation, showed that adenine, a…

A research study led by Massachusetts General Hospital reveals four blood biomarkers that can help predict risk for kidney and heart disease in people with type 2 diabetes and high levels of albumin in their urine. The study, which is published in the journal Circulation, showed that high levels of…

New research from the University of Georgia has found that a specific regimen of time-restricted eating may prevent Type 2 diabetes (T2D) and obesity. A form of intermittent fasting, time-restricted eating is characterized by having regular but fewer meals, and cutting out late night snacking, while not eating for 12…

Results from a study led by researchers at the Garvan Institute of Medical Research in Australia show how treatment with anti-inflammatory steroids can affect a gene called RELA and trigger diabetes symptoms. The results of the research, published in the journal Diabetologia, suggest that RELA plays a joint role in…

Researchers from the University of Minnesota (U OF M) Medical School have found that the diabetes drug metformin lowers the risk of developing long COVID. The results of their study, called COVID-OUT which examined whether early outpatient treatment with metformin, ivermectin, or fluvoxamine could precent long COVID were published in…

One in three adults with Type 2 diabetes have elevated levels of biomarkers of cardiovascular disease, even if they do not have symptoms, new research says. This work supports the idea that screening for cardiac biomarkers should be added to routine cardiovascular risk assessment. It also suggests new types of…

Results from a large Canadian study suggest that infection with the SARS-CoV-2 virus increases a person’s risk for developing diabetes by a small but significant percentage. Writing in the journal JAMA Network Open, Naveed Janjua, PhD, a professor at the University of British Columbia and executive director of data and…

Aspect Biosystems and Novo Nordisk A/S this week announced an agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body for treatment of diabetes and obesity. The collaboration will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell…

Researchers from the University of Edinburgh, Scotland, say they have developed a method of analyzing DNA methylation from a blood sample that, along with other patient risk factors, can improve the ability to predict the development of type 2 diabetes within the next 10 years. Current prediction tools for type…

Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new Northwestern Medicine study. Making screening decisions based on age alone is also simpler for clinicians to implement, which may result in greater uptake of such testing.…

A peptide called PEPITEM could provide a new approach to reducing the risk of type 2 diabetes and other obesity-related diseases, such as hepatic steatosis (fatty liver), according to research based on animal studies published today in Clinical & Experimental Immunology. “We have found a new therapeutic approach that could…

Childhood obesity is associated with an increased risk of four of the five subtypes of adult-onset diabetes, according to new research using data from the UK Biobank and Mendelian randomization (MR). The authors say their study potentially reveals different mechanisms linking childhood adiposity to different diabetes subtypes. The study was…